Contribution of MASK-air® as a mHealth tool for digitally-enabled person-centred care in rhinitis and asthma DOI Open Access
Bernardo Sousa‐Pinto,

JA Fonseca,

Jean Bousquet

et al.

Journal of Investigational Allergology and Clinical Immunology, Journal Year: 2024, Volume and Issue: 34(3), P. 148 - 156

Published: May 14, 2024

In chronic diseases, mHealth apps help to improve clinical management and provide valuable real-world scientific evidence. allergic rhinitis, a market research study identified only 4 that were multilingual, resulted in publications, displayed comprehensive list of medications. Of these apps, MASK-air® generated the highest number publications. MASK-air was launched 2015 is currently available 30 countries, with data collected from more than 000 users. It comprises daily monitoring questionnaire, enabling patients register their allergy symptoms by means visual analog scales medication use. The achievements include development 2 digital biomarkers for rhinitis asthma (combined symptom-medication score electronic control score). have also made it possible assess patients’ behavior, suggesting do not follow guideline recommendations, but rather treat themselves (and often use comedication) when they feel worse. Using data, we quantified impact diseases on quality life school work productivity. Realworld are being used as source evidence Allergic Rhinitis its Impact Asthma 2024 guidelines an innovative process incorporation mobile health into guidelines. This review discusses contributions person-centred care asthma, providing illustrative example diseases.

Language: Английский

ARIA–Italy managing allergic rhinitis and asthma in a changing world: The role of the Pharmacist DOI Creative Commons
Giovanni Paoletti, Corrado Giua,

Alessandro Marti

et al.

World Allergy Organization Journal, Journal Year: 2025, Volume and Issue: 18(5), P. 101055 - 101055

Published: April 25, 2025

Language: Английский

Citations

0
Contribution of MASK-air® as a mHealth tool for digitally-enabled person-centred care in rhinitis and asthma DOI Open Access
Bernardo Sousa‐Pinto,

JA Fonseca,

Jean Bousquet

et al.

Journal of Investigational Allergology and Clinical Immunology, Journal Year: 2024, Volume and Issue: 34(3), P. 148 - 156

Published: May 14, 2024

In chronic diseases, mHealth apps help to improve clinical management and provide valuable real-world scientific evidence. allergic rhinitis, a market research study identified only 4 that were multilingual, resulted in publications, displayed comprehensive list of medications. Of these apps, MASK-air® generated the highest number publications. MASK-air was launched 2015 is currently available 30 countries, with data collected from more than 000 users. It comprises daily monitoring questionnaire, enabling patients register their allergy symptoms by means visual analog scales medication use. The achievements include development 2 digital biomarkers for rhinitis asthma (combined symptom-medication score electronic control score). have also made it possible assess patients’ behavior, suggesting do not follow guideline recommendations, but rather treat themselves (and often use comedication) when they feel worse. Using data, we quantified impact diseases on quality life school work productivity. Realworld are being used as source evidence Allergic Rhinitis its Impact Asthma 2024 guidelines an innovative process incorporation mobile health into guidelines. This review discusses contributions person-centred care asthma, providing illustrative example diseases.

Language: Английский

Citations

2